Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Ling Wang

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Oncotarget|April 8, 2017
Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitorsYing Ma, Hui-Yu Wei, Yu-Ze Zhang, et al.
International Journal of Molecular Sciences|June 19, 2013
Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2Su-Xia Sun, Xiao-Bo Li, Wen-Bo Liu, et al.
Journal of Biomolecular Structure & Dynamics|September 7, 2019
Design, synthesis, biological evaluation and molecular dynamics studies of 4-thiazolinone derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitorsWen-Shan Liu, Rui-Rui Wang, Hai Yue, et al.
Bioorganic Chemistry|May 8, 2020
Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitorsWen-Shan Liu, Bing Yang, Rui-Rui Wang, et al.
The Journal of Organic Chemistry|October 28, 2016
An Approach to Optically Pure Bridging Chiral p-tert-Butylcalix[4]arenes through a Homologous Anionic Ortho-Fries RearrangementWen-Qiang Xu, Wen-Shan Liu, Jiu-Xing Yan, et al.
Journal of Cellular Biochemistry|May 25, 2019
Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulationWen-Shan Liu, Rui-Rui Wang, Ying-Zhan Sun, et al.
Molecular Diversity|January 4, 2021
Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2<sup>E69K</sup>Shan Du, Xin-Hua Lu, Wei-Ya Li, et al.
Journal of Biomolecular Structure & Dynamics|December 3, 2019
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approachJing-Wei Wu, Huan Zhang, Wei-Ya Li, et al.
Oncotarget|April 28, 2017
Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARgJun Zhang, Qing-Qing Hao, Xin Liu, et al.
Journal of Molecular Graphics & Modelling|December 18, 2020
Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 <sup>WT</sup> and SHP2<sup>F285S</sup> by molecular dynamics studyLiang Zhou, Yong Feng, Yang-Chun Ma, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Oncotarget|April 8, 2017
Synthesis, bioactivity, 3D-QSAR studies of novel dibenzofuran derivatives as PTP-MEG2 inhibitorsYing Ma, Hui-Yu Wei, Yu-Ze Zhang, et al.
International Journal of Molecular Sciences|June 19, 2013
Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2Su-Xia Sun, Xiao-Bo Li, Wen-Bo Liu, et al.
Journal of Biomolecular Structure & Dynamics|September 7, 2019
Design, synthesis, biological evaluation and molecular dynamics studies of 4-thiazolinone derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitorsWen-Shan Liu, Rui-Rui Wang, Hai Yue, et al.
Bioorganic Chemistry|May 8, 2020
Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitorsWen-Shan Liu, Bing Yang, Rui-Rui Wang, et al.
The Journal of Organic Chemistry|October 28, 2016
An Approach to Optically Pure Bridging Chiral p-tert-Butylcalix[4]arenes through a Homologous Anionic Ortho-Fries RearrangementWen-Qiang Xu, Wen-Shan Liu, Jiu-Xing Yan, et al.
Journal of Cellular Biochemistry|May 25, 2019
Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulationWen-Shan Liu, Rui-Rui Wang, Ying-Zhan Sun, et al.
Molecular Diversity|January 4, 2021
Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2<sup>E69K</sup>Shan Du, Xin-Hua Lu, Wei-Ya Li, et al.
Journal of Biomolecular Structure & Dynamics|December 3, 2019
Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approachJing-Wei Wu, Huan Zhang, Wei-Ya Li, et al.
Oncotarget|April 28, 2017
Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARgJun Zhang, Qing-Qing Hao, Xin Liu, et al.
Journal of Molecular Graphics & Modelling|December 18, 2020
Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 <sup>WT</sup> and SHP2<sup>F285S</sup> by molecular dynamics studyLiang Zhou, Yong Feng, Yang-Chun Ma, et al.
Pageof 6